Atrium Therapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2024 | — | $-61.1M | $0 |
| Mar 2025 | — | $-56.3M | $0 |
| Jun 2025 | — | $-56.2M | $0 |
| Dec 2025 | — | $-62.7M | $0 |
| Mar 2026 | — | $234.1M | $267.8M |
| Jun 2026 | — | $214.6M | $72.3M |
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2024 | — | $-61.1M | $0 |
| Mar 2025 | — | $-56.3M | $0 |
| Jun 2025 | — | $-56.2M | $0 |
| Dec 2025 | — | $-62.7M | $0 |
| Mar 2026 | — | $234.1M | $267.8M |
| Jun 2026 | — | $214.6M | $72.3M |